Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients

Journal of Clinical Psychiatry

Volumn 73, Issue 7, 2012, Pages 924-930

  Post, Robert M ^a   Leverich, Gabriele S ^a   Altshuler, Lori L ^b   Frye, Mark A ^d   Suppes, Trisha ^c   McElroy, Susan L ^e   Keck, Paul E ^e   Nolen, Willem A ^f   Rowe, Mike ^a   Kupka, Ralph W ^g   Grunze, Heinz ^h   Goodwin, Frederick K ^i,j  

^a Bipolar Collaborative Network   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MAYO CLINIC   (United States)

^e Linder Center of Hope   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ NEWCASTLE UNIVERSITY   (United Kingdom)

^j GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; MOOD STABILIZER;

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR I DISORDER; COMORBIDITY; DISEASE COURSE; DRUG EXPOSURE; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; OUTPATIENT; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84864399130     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07396     Document Type: Article

References (47)

1. Davis JM, Wang Z, Janicak PG. A quantitative analysis of clinical drug trials for the treatment of affective disorders. Psychopharmacol Bull. 1993;29(2):175-181. PubMed (Pubitemid 23311521)
2. Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet. 2003;361(9358):653-661. doi:10.1016/S0140-6736(03)1259-8 PubMed (Pubitemid 36246547)
3. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007;356(17):1711-1722. doi:10.1056/NEJMoa064135 PubMed (Pubitemid 46658703)
4. McElroy SL, Frye MA, Hellemann G, et al. Prevalence and correlates of eating disorders in 875 patients with bipolar disorder. J Affect Disord 2011;128(3):191-198. PubMed
5. Ghaemi SN, Ostacher MM, El-Mallakh RS, et al. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry. 2010;71(4):372-380. doi:10.408/JCP.08m04909gre PubMed
6. Ghaemi S, El-Mallakh R, Baldassano C, et al. Antidepressant Effect on Long-Term Mood Morbidity in Bipolar Disorder. Presented at the 161st Annual Meeting of the American Psychiatric Association; May 3-8, 2008; Washington, DC.
7. Ghaemi SN, Wingo AP, Filkowski MA, et al. Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr Scand. 2008;118(5):347-356. doi:10.1/j.160-047.208.01257.x PubMed
8. Post RM, Leverich GS. Treatment of Bipolar Illness: A Casebook for Clinicians and Patients. New York, NY: W W Norton; 2008.
9. Altshuler LL, Post RM, Leverich GS, et al. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry. 1995;152(8):1130-1138. PubMed
10. Koukopoulos A, Reginaldi D, Minnai G, et al. The long term prophylaxis of affective disorders. Adv Biochem Psychopharmacol. 1995;49:127-147. PubMed
11. Sidor MM, MacQueen GM. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. J Clin Psychiatry. 2011;72(2):156-167. doi:10.408/JCP.09r05385gre PubMed
12. Post RM, Altshuler LL, Leverich GS, et al. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry. 2006;189(2):124-131. doi:10.192/bjp.bp.105.013045 PubMed (Pubitemid 44231270)
13. Vieta E, Martinez-Arán A, Goikolea JM, et al. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry. 2002;63(6):508-512. doi:10.408/JCP.v63n0607 PubMed
14. Sachs GS, Lafer B, Stoll AL, et al. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry. 1994;55(9):391-393. PubMed (Pubitemid 24337995)
15. Martin A, Young C, Leckman JF, et al. Age effects on antidepressant- induced manic conversion. Arch Pediatr Adolesc Med. 2004;158(8):773-780. doi:10.101/archpedi.158.8.73 PubMed (Pubitemid 39025076)
16. Gijsman HJ, Geddes JR, Rendell JM, et al. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry. 2004;161(9):1537-1547. doi:10.176/api.ajp.161.9.1537 PubMed (Pubitemid 39201448)
17. Frye MA, Helleman G, McElroy SL, et al. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry. 2009;166(2):164-172. doi:10.176/api.ajp.208.0803032 PubMed
18. Goldberg JF, Perlis RH, Ghaemi SN, et al. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry. 2007;164(9):1348-1355. doi:10.176/api.ajp.207.0512032 PubMed (Pubitemid 47461134)
19. Altshuler L, Kiriakos L, Calcagno J, et al. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. J Clin Psychiatry. 2001;62(8):612-616. doi:10.408/JCP.v62n0807 PubMed (Pubitemid 32848165)
20. Altshuler L, Suppes T, Black D, et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry. 2003;160(7):1252-1262. doi:10.176/api.ajp.160.7.1252 PubMed (Pubitemid 41070941)
21. Joffe RT, MacQueen GM, Marriott M, et al. One-year outcome with antidepressant - treatment of bipolar depression. Acta Psychiatr Scand. 2005;112(2):105-109. doi:10.1/j.160-047.205.0583.x PubMed (Pubitemid 41003188)
22. Post RM, Nolen WA, Kupka RW, et al. The Stanley Foundation Bipolar Network, 1:rationale and methods. Br J Psychiatry suppl. 2001;178(41):s169-s176. doi:10.192/bjp.178.41.s169 PubMed (Pubitemid 32530347)
23. Post RM, Leverich GS, Kupka RW, et al. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry. 2010;71(7):864-872. doi:10.408/JCP.08m0494yel PubMed
24. Post RM, Altshuler L, Frye MA, et al. Complexity of pharmacological treatment required for sustained improvement in outpatients with bipolar disorder. J Clin Psychiatry. 2010;71(9):1176-1186. doi:10.408/JCP.08m0481yel PubMed
25. Kupka RW, Luckenbaugh DA, Post RM, et al. Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Am J Psychiatry. 2005;162(7):1273-1280. doi:10.176/api.ajp.162.7. 1273 PubMed (Pubitemid 40905577)
26. Amsterdam JD, Shults J. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. Am J Psychiatry. 2010;167(7):792-800. doi:10.176/api.ajp.209.09020284 PubMed
27. Altshuler LL, Suppes T, Black DO, et al. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. Am J Psychiatry. 2006;163(2):313-315. doi:10.176/api.ajp.163.2.313 PubMed (Pubitemid 44480853)
28. Leverich GS, Altshuler LL, Frye MA, et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry. 2006;163(2):232-239. doi:10.176/api.ajp.163. 2.232 PubMed (Pubitemid 44480842)
29. Nolen WA, Luckenbaugh DA, Altshuler LL, et al. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network. Am J Psychiatry. 2004;161(8):1447-1454. doi:10.176/api.ajp.161. 8.147 PubMed (Pubitemid 38989099)
30. Post RM, Denicoff KD, Leverich GS, et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry. 2003;64(6):680-690; quiz 738-739. PubMed
31. Leverich GS, Post RM. Course of bipolar illness after history of childhood trauma. Lancet. 2006;367(9516):1040-1042. doi:10.1016/S0140-6736(06) 68450-X PubMed
32. Post RM, Leverich GS, Altshuler LL, et al. Differential clinical characteristics, medication usage, and treatment response in the US versus the Netherlands and Germany. Int Clin Psychopharmacol. 2011;26(2):96-106. PubMed
33. Post RM, Luckenbaugh DA, Leverich GS, et al. Incidence of childhood-onset bipolar illness in the USA and Europe. Br J Psychiatry. 2008;192(2):150-151. doi:10.192/bjp.bp.107.037820 PubMed (Pubitemid 351269650)
34. Kauer-San't Anna M, Kapczinski F, Vieta E. Epidemiology and management of anxiety in patients with bipolar disorder. CNS Drugs. 2009;23(11):953-964. PubMed doi:10.2165/1310850-0-0
35. Frank E, Cyranowski JM, Rucci P, et al. Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder. Arch Gen Psychiatry. 2002;59(10):905-911. doi:10.101/archpsyc.59.10.905 PubMed
36. Simon NM, Otto MW, Wisniewski SR, et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEPBD). Am J Psychiatry. 2004;161(12):2222-2229. doi:10.176/api.ajp.161.12.2 PubMed (Pubitemid 39587287)
37. Albert U, Rosso G, Maina G, et al. Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J Affect Disord. 2008;105(1-3):297-303. doi:10.1016/j.jad.207.05.020 PubMed (Pubitemid 350236370)
38. Lee JH, Dunner DL. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders. Depress Anxiety. 2008;25(2):91-97. doi:10.102/da.20279 PubMed (Pubitemid 351341954)
39. Coryell W, Solomon DA, Fiedorowicz JG, et al. Anxiety and outcome in bipolar disorder. Am J Psychiatry. 2009;166(11):1238-1243. doi:10.176/api.ajp. 209.09020218 PubMed
40. Baldessarini RJ, Leahy L, Arcona S, et al. Patterns of psychotropic drug prescription for US patients with diagnoses of bipolar disorders. Psychiatr Serv. 2007;58(1):85-91. doi:10.176/api.ps.58.1.85 PubMed
41. Perlis RH, Dennehy EB, Miklowitz DJ, et al. Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disord. 2009;11(4):391-400. doi:10.1/j.139-5618.209.0686. x PubMed
42. Perlis RH, Miyahara S, Marangell LB, et al STEP-BD Investigators. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2004;55(9):875-881. doi:10.1016/j.biopsych. 204.01.02 PubMed (Pubitemid 38526299)
43. Post RM. Preface and Overview. Clin Neurosci Res. 2002;2(3-4):122-126. doi:10.1016/S156-272(02)037-3 (Pubitemid 35375327)
44. Post RM. Childhood onset bipolar disorder: the perfect storm. Psychiatr Ann. 2009;39(10):879-886. doi:10.3928/0485718-2090924-06
45. Post RM, Kowatch RA. The health care crisis of childhood-onset bipolar illness: some recommendations for its amelioration. J Clin Psychiatry. 2006;67(1):115-125. doi:10.408/JCP.v67n018 PubMed (Pubitemid 43213292)
46. Post R, Leverich G, Speer A. Bipolar illness: which critical treatment issues need study? Clin App in Bipolar Disorder. 2003;2:24-30.
47. McElroy SL, Weisler RH, Chang W, et al; EMBOLDEN II (Trial D1447C00134) Investigators. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry. 2010;71(2):163-174. doi:10.408/JCP.08m04942gre PubMed